Intellipharmaceutics International Inc. (IPCIQ)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 19, 2025
-100.00%
Market Cap n/a
Revenue (ttm) 904.95K
Net Income (ttm) -3.17M
Shares Out n/a
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 430
Average Volume 12,662
Open 0.0000
Previous Close 0.0000
Day's Range 0.0000 - 0.0000
52-Week Range 0.0213 - 0.1500
Beta n/a
RSI 42.33
Earnings Date Feb 28, 2025

About IPCIQ

Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for... [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 11
Stock Exchange OTCMKTS
Ticker Symbol IPCIQ
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.